Galaxy Biomedical Investment Co., Ltd.

Symboli: 000806.SZ

SHZ

0.43

CNY

Markkinahinta tänään

  • -1.1415

    P/E-suhde

  • 0.0445

    PEG-suhde

  • 494.96M

    MRK Cap

  • 0.00%

    DIV Tuotto

Galaxy Biomedical Investment Co., Ltd. (000806-SZ) Tilinpäätöstiedotteet

Kaaviossa näet oletusarvot Galaxy Biomedical Investment Co., Ltd. (000806.SZ). Yrityksen liikevaihto näyttää NaN M keskiarvon, joka on NaN % gowth. Koko jakson keskimääräinen bruttovoitto on NaN M, joka on NaN %. Keskimääräinen bruttovoittosuhde on NaN %. Yrityksen viime vuoden tuloksen nettotuloksen kasvu on NaN %, joka on NaN % % keskimäärin koko yrityksen historian aikana.,

Tase

Galaxy Biomedical Investment Co., Ltd. verotukselliseen kehitykseen sukeltamalla havaitsemme keskimääräisen varallisuuden kasvun. Tämä korko on mielenkiintoisesti , mikä heijastaa sekä yrityksen huippuja että matalimpia lukemia. Neljännesvuosittaisessa vertailussa tämä luku on . Kun tarkastellaan viime vuotta taaksepäin, kokonaisvarojen muutos on NaN. Osakkeenomistajien arvo, jota kuvaa osakepääoman kokonaismäärä, arvostetaan NaN raportointivaluutassa. Tämän näkökohdan vuosittainen muutos on NaN%.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

081.184.6134.8
100.4
50.7
265.9
470
569.9
312
83
120.5
203.5
347.1
211.2
114.5
146.7
88.5
234.2
336.9
561.3
620.4
165.4
90.5
80.5
40.3
9.6
1.8
1.1
1.6

balance-sheet.row.short-term-investments

03.1-64.124.8
-53.9
-54.4
0
67.3
0
0
0
0
0
59
0
0
0.6
0
1.3
0
1.6
51.7
0.9
0
34
0
0
0
0
0

balance-sheet.row.net-receivables

01177.4759.41146.2
696.1
1414.1
1208.3
725.7
778.2
747.4
689.6
783.9
945.8
1442.6
1747.5
1265.7
1292.5
1140.1
978.8
1060
859.5
564.5
378.5
180.2
54.9
45.3
17.2
11.2
16.6
13.4

balance-sheet.row.inventory

0199.6280.5233.4
259.5
230.2
482.7
455.9
390.4
329.3
311.9
252.1
351.1
285.1
319.1
379.9
328.6
399.7
315.2
274.8
249.3
155.8
136.3
63.5
45.9
79.2
51.9
55.7
33.2
38.5

balance-sheet.row.other-current-assets

04.785.5
8.8
21
156.4
144.9
70
2.3
0.7
-105.3
0.5
-271.8
-360.8
0.1
0.5
0
0
119.8
-270
0.8
1
159.5
106.6
89.7
52
30.4
25
16

balance-sheet.row.total-current-assets

01462.81132.41519.9
1064.8
1716.1
2113.3
1796.5
1808.4
1390.9
1085.2
1051.1
1500.9
1803
1917
1760.1
1768.3
1628.4
1528.3
1791.5
1400.2
1341.4
681.2
493.6
287.9
254.5
130.6
99
76
69.5

balance-sheet.row.property-plant-equipment-net

0253.5285.9274.1
283
308.8
328.7
377.8
377.4
385.5
412.1
440.5
451.5
456.2
414.7
902.5
1021.6
1383.9
1396.3
974.5
869.1
670.4
398.2
267.5
218.5
192.4
82.1
78.4
68.9
32.2

balance-sheet.row.goodwill

0000
0
0
27.3
165.1
189.1
26
26
26
26
26
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0113115.9121.4
125
127.9
157.7
170.2
188.8
212.3
222
232.3
249.8
266
238.6
237
228.1
84.6
94.1
63
62.7
22
14.3
12.8
11.5
5.8
4.8
1.2
1.4
1.5

balance-sheet.row.goodwill-and-intangible-assets

0113115.9121.4
125
127.9
185
335.3
377.9
238.3
247.9
258.3
275.8
292
238.6
237
228.1
84.6
94.1
63
62.7
22
14.3
12.8
11.5
5.8
4.8
1.2
1.4
1.5

balance-sheet.row.long-term-investments

091.4178.596.2
210.6
292.4
329.7
41.1
77.4
103.3
197.3
220.3
168.5
134.7
320.4
0
638.6
0
266.4
0
153.5
75.7
99
0
-20.5
0
0
0
0
0

balance-sheet.row.tax-assets

019.221.329.1
25.9
28.3
58.6
40.2
48.7
75.2
79.8
79.5
82.1
74.5
53.8
68.4
63
0
3.3
0
0
58.5
5.2
0
34.3
0
0
0
0
0

balance-sheet.row.other-non-current-assets

066.62.285.8
9.7
8.6
677.7
295.7
87.4
114.9
257.9
281
229.2
140.9
381
301.8
48.6
288.6
3.9
223.6
7
72.6
20.2
108.8
67.2
11.1
9
9.4
9.3
9.4

balance-sheet.row.total-non-current-assets

0543.7603.8606.7
654.3
766
1250
1090
891.4
813.8
997.9
1059.3
1038.7
1098.3
1088.2
1509.6
1975.6
1757.1
1760.7
1261.1
1092.4
840.7
531.7
389.1
276.7
209.3
95.9
89
79.6
43.2

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

02006.51736.22126.6
1719.1
2482.1
3363.3
2886.5
2699.8
2204.8
2083.1
2110.4
2539.6
2901.4
3005.2
3269.8
3743.8
3385.5
3289
3052.6
2492.5
2182.2
1212.9
882.7
564.7
463.8
226.5
188
155.6
112.6

balance-sheet.row.account-payables

0285.4261304.1
339.8
265.8
295.2
301
289.7
453.2
271
226.3
260
242.1
193.5
318.6
156.7
216.6
98.9
173.5
165.9
99.5
51.9
17.9
8.8
19
7.7
30.5
19.8
8.4

balance-sheet.row.short-term-debt

0189.2109.399.4
122.2
530.5
229
209
95
628
517.9
497
761.7
725.4
827.2
1065.6
1037
1268.3
1401.8
1062
933.8
688.7
505.7
314
65
46.3
50.7
15
13.3
4.7

balance-sheet.row.tax-payables

045.528.720.6
10
11.5
20.9
12.8
16.1
15.9
9.9
7.4
4.1
21.3
22.9
22.8
45.1
5.1
14.6
23.4
17.3
18
20.1
12.7
20.1
15.5
4.6
7.4
3.1
3

balance-sheet.row.long-term-debt-total

09.310.659
60
0
380
30
0
64
174
296.5
296.5
542.5
340.1
290.2
355.6
421.3
221.7
238.5
201.7
117.1
91.3
92.6
111.6
66.6
0
0
0
0

Deferred Revenue Non Current

036.341.244.4
52.4
52.6
58.6
56
57.2
55.7
1.5
1.5
2.8
23.6
88.7
36.4
36.5
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

056918.1310.2
460.8
228.8
213.2
178.1
189.9
151.7
183.4
144.3
306
226
296.7
402.4
504.1
339.6
257.3
237.7
-94.2
141.4
102.2
68.5
60.5
30.3
14.2
27.7
40.4
25.6

balance-sheet.row.total-non-current-liabilities

02205.71830.1924.8
485.5
55
449.2
86.6
57.3
129.1
249
377
379
659.9
478.5
362.9
469.9
463.6
266.5
281.6
244.1
158.6
100.1
101.5
120.8
82.2
0
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

08.710.60
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

03249.42631.12063.9
1701.1
1091.5
1186.6
774.6
631.9
1362
1221.3
1244.5
1706.6
1853.5
1795.9
2149.5
2167.8
2288.1
2024.5
1754.9
1249.6
1088.2
759.9
501.8
255.1
177.8
72.6
73.2
73.5
38.7

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

01099.91099.91099.9
1099.9
1099.9
1099.9
1099.9
1099.9
699.2
699.2
699.2
699.2
699.2
699.2
699.2
635.6
635.6
418.7
349
303.4
303.4
211.6
211.6
162.8
82.2
61.2
61.2
61.2
61.2

balance-sheet.row.retained-earnings

0-3534.5-3175-2195.6
-2253.9
-908.3
-202.7
-212.3
-225.2
-327.7
-353.8
-366
-390.1
-211.7
-137.5
-177.5
27.3
-34.6
158.2
158.9
208.2
133.2
113.8
58
53.5
65.1
40.4
18
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

01181.51189.51162.6
1178.1
1194.3
1208.7
1146.1
1138.1
447.5
490
506.4
499.3
525.7
611.1
560.6
859.2
461.8
663.1
768.4
713
643.2
119.1
102
83.9
129.4
27.8
23.8
12.9
5

balance-sheet.row.total-stockholders-equity

0-1253-885.666.9
24.1
1385.9
2105.9
2033.8
2012.8
819
835.5
839.7
808.5
1013.2
1172.7
1082.3
1522.1
1062.8
1240
1276.3
1224.6
1079.8
444.5
371.6
300.2
276.7
129.4
103
74.1
66.2

balance-sheet.row.total-liabilities-and-stockholders-equity

02006.51736.22126.6
1719.1
2482.1
3363.3
2886.5
2699.8
2204.8
2083.1
2110.4
2539.6
2901.4
3005.2
3269.8
3743.8
3385.5
3289
3052.6
2492.5
2182.2
1212.9
882.7
564.7
463.8
226.5
188
157.6
112.6

balance-sheet.row.minority-interest

010.2-9.3-4.2
-6.1
4.7
70.8
78.1
55.1
23.8
26.3
26.2
24.5
34.7
36.5
37.9
53.9
34.6
24.4
21.4
18.3
14.1
8.6
9.4
9.4
9.3
24.6
11.8
9.9
7.8

balance-sheet.row.total-equity

0-1242.8-894.962.7
18
1390.6
2176.7
2111.9
2067.9
842.8
861.8
865.9
832.9
1047.9
1209.3
1120.2
1576.1
1097.4
1264.4
1297.7
1242.9
1094
453
381
309.6
286
154
114.8
84
73.9

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

094.5114.4121
156.7
238
208.9
108.4
74
101.7
196.5
219.4
163.5
193.7
295.1
275.6
639.2
286.7
267.7
219.8
155.1
127.5
99.9
87.1
13.5
9.1
0
0
0
0

balance-sheet.row.total-debt

0198.5119.9158.4
182.2
530.5
609
239
95
692
691.9
793.5
1058.2
1267.9
1167.3
1355.8
1392.6
1689.6
1623.5
1300.5
1135.5
805.8
597
406.6
176.6
112.8
50.7
15
13.3
4.7

balance-sheet.row.net-debt

0120.535.348.4
81.8
479.8
343.1
-163.8
-474.9
380
608.8
673
854.7
979.8
956
1241.3
1246.5
1601
1390.6
963.6
575.8
237.1
432.5
316.1
130
72.5
41.1
13.2
12.2
3.1

Kassavirtalaskelma

Galaxy Biomedical Investment Co., Ltd. taloudessa on tapahtunut huomattava muutos vapaan kassavirran määrässä viimeisen ajanjakson aikana, ja se on muuttunut NaN suuntaan. Yhtiö on hiljattain laajentanut osakepääomaansa laskemalla liikkeeseen NaN, mikä merkitsee NaN eroa edelliseen vuoteen verrattuna. Yhtiön investointitoiminnasta aiheutui nettokassan käyttöä, joka oli NaN raportointivaluutassa. Tämä on NaN siirtymä edellisestä vuodesta. Samana ajanjaksona yhtiö kirjasi NaN, NaN ja NaN, jotka ovat merkittäviä yrityksen investointi-ja takaisinmaksustrategioiden ymmärtämisen kannalta. Yhtiön rahoitustoiminta johti siihen, että nettokassan käyttö oli NaN, ja ero edellisvuoteen oli {{year_over_year_net_cash_from_financing_activities_change_percentage}}. Lisäksi yhtiö osoitti NaN osingonjakoon osakkeenomistajilleen. Samaan aikaan se toteutti myös muita rahoitusmanöövereitä, joihin viitataan nimellä {{other-financing-activities}}, jotka myös vaikuttivat merkittävästi sen kassavirtaan kyseisenä ajanjaksona. Nämä osatekijät muodostavat yhdessä kattavan kuvan yrityksen taloudellisesta tilanteesta ja strategisesta lähestymistavasta kassavirran hallintaan.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

0-336.6-968.562.1
-1169.5
-736.3
14.6
16.4
102.6
23
12.4
25.9
-187.6
-57.6
51.4
-185.6
26.2
-180.9
10.2
143.2
127.4
79
93.4
89
49.2
30.7

cash-flows.row.depreciation-and-amortization

046.947.428.2
32.1
44.3
42.7
42.2
57.5
46.7
46.6
46.5
49.2
47.8
45.6
85.8
100.8
87.5
86.6
62.4
33.3
27.8
18.8
18.6
15.7
5.3

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-229.6-94.8-74.1
345.8
-140.5
-124.9
15.8
-140.4
-11.2
-8.4
250.8
214
142.8
-286.7
-228.9
-73.6
-127.6
-197.2
-319.4
1.6
-71.3
-69.8
-84.7
-76.6
-39.7

cash-flows.row.account-receivables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

080.9-47.726.7
-22.1
89.4
-24.1
-65.5
-61.1
-17.4
-59.8
99
-66
37.1
60.8
-52.2
72.7
-97.6
-42.6
-25.4
-93.6
31
-72.9
-17.6
-6.8
-20.4

cash-flows.row.account-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-310.5-47.1-100.8
367.9
-229.9
-100.8
81.3
-79.3
6.2
51.4
151.8
280
105.7
-347.5
-176.7
-146.3
-30.1
-154.6
-294
95.1
-102.3
3
-67.1
-69.9
-19.3

cash-flows.row.other-non-cash-items

0485.3988.528.5
854.9
468.2
0.5
12
-117.4
-9.2
13.4
-19.9
181.3
118.5
-5
297.9
128.2
174.5
122.1
39.2
14.3
28.2
20.5
10
1
6.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-7-22.1-18.6
-11.4
-13.9
-65.2
-38.5
-20
-9.3
-8.4
-23.3
-59.9
-124.3
-126.4
-18.4
-15.9
-112.5
-104.6
-181.7
-251.4
-253.8
-96.9
-169.2
-16
-98

cash-flows.row.acquisitions-net

000.819.6
19.2
97.5
0.7
0.4
-166
0
0
0
11.1
0.9
396.4
27.9
0
8.5
0
181.8
264.6
3.3
0.2
0
16
99.8

cash-flows.row.purchases-of-investments

0-64.7-282.3-220.1
-170.1
-263.8
-1142.3
-570.9
-216.9
-3
0
-65
-0.5
-105.6
-10
-13
-7.1
-0.8
-79.1
-74.8
-151.6
-145.8
-58.3
-76.2
-55.5
-2.1

cash-flows.row.sales-maturities-of-investments

077.2315.6212.9
202.8
372.6
795.7
199.2
285.7
138.6
63.5
23.3
118.2
22.8
243.4
95.4
142
2.3
6.9
14
194.5
56.1
3.2
52.7
30.9
5.1

cash-flows.row.other-investing-activites

01.32.2-18.6
1.5
13.6
31.7
6.4
43.5
-9.2
15
15.4
14.3
69.1
26.3
15.1
127.5
15.1
3.1
0
13.2
3
0.3
2.7
0
1.8

cash-flows.row.net-cash-used-for-investing-activites

06.914.4-24.8
41.9
205.9
-380.1
-403.8
-73.7
117.1
70.1
-49.6
72.1
-137.1
529.7
107.1
246.5
-95.9
-173.8
-242.5
-195.3
-340.6
-151.8
-190
-40.5
-93.2

cash-flows.row.debt-repayment

0-80.9-25-26
-131.9
-162
-424
-105
-708
-736.8
-585.8
-873.3
-998.2
-1145.8
-884.4
-419.5
-764.9
-1233.1
-1539
-847.2
-848.7
-648.8
-379.5
-111
-44.8
-117.8

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-4.7-4.8-8
-17
-35.1
-15.2
-7.1
-17.6
-50.1
-52.4
-73.2
-110.4
-170.2
-112.8
-64.6
-58.6
-101.1
-86.4
-70.7
-49.9
-43.5
-48.9
-25.5
-7.2
-16.4

cash-flows.row.other-financing-activites

010419.721.6
77.6
159.5
763.7
260.7
1250.7
732.8
481.4
605.6
762.4
1216.8
713
376.2
452.7
1332.3
1673.4
1012.2
908.4
1373.3
577.8
337.3
111.8
251.5

cash-flows.row.net-cash-used-provided-by-financing-activities

018.4-10.1-12.4
-71.3
-37.6
324.5
148.5
525.2
-54.1
-156.8
-340.9
-346.1
-99.2
-284.2
-108
-370.8
-1.9
48.1
94.4
9.8
681
149.3
200.9
59.8
117.4

cash-flows.row.effect-of-forex-changes-on-cash

00.3-0.10.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.5

cash-flows.row.net-change-in-cash

0-8.4-237.5
33.9
-195.9
-122.6
-168.9
353.8
112.5
-22.7
-87.3
-17.2
15.3
50.8
-31.6
57.2
-144.3
-104
-222.8
-8.9
404.1
60.4
43.9
8.5
26.9

cash-flows.row.cash-at-end-of-period

042.250.673.6
66.1
32.2
228.1
350.7
519.7
165.9
53.4
76.1
163.4
180.6
165.3
114.5
146.1
88.5
232.9
336.9
559.7
568.6
165.4
90.5
46.6
40.3

cash-flows.row.cash-at-beginning-of-period

050.673.666.1
32.2
228.1
350.7
519.7
165.9
53.4
76.1
163.4
180.6
165.3
114.5
146.1
88.9
232.9
336.9
559.7
568.6
164.5
105
46.6
38
13.4

cash-flows.row.operating-cash-flow

0-34-27.344.7
63.2
-364.3
-67.1
86.4
-97.7
49.4
64
303.3
256.9
251.6
-194.7
-30.7
181.5
-46.6
21.7
-74.7
176.6
63.6
62.8
33
-10.7
2.3

cash-flows.row.capital-expenditure

0-7-22.1-18.6
-11.4
-13.9
-65.2
-38.5
-20
-9.3
-8.4
-23.3
-59.9
-124.3
-126.4
-18.4
-15.9
-112.5
-104.6
-181.7
-251.4
-253.8
-96.9
-169.2
-16
-98

cash-flows.row.free-cash-flow

0-41-49.326.1
51.8
-378.3
-132.3
47.9
-117.6
40.1
55.6
279.9
197
127.3
-321.1
-49.1
165.6
-159.1
-82.9
-256.4
-74.8
-190.1
-34.1
-136.2
-26.7
-95.7

Tuloslaskelmarivi

Galaxy Biomedical Investment Co., Ltd. liikevaihto muuttui NaN% edelliseen kauteen verrattuna. 000806.SZ:n bruttovoitto ilmoitetaan NaN. Yrityksen toimintakulut ovat NaN, ja niissä on tapahtunut NaN%:n muutos edelliseen vuoteen verrattuna. Poistojen ja arvonalentumisten kulut ovat NaN, mikä on NaN% muutos edellisestä tilikaudesta. Toimintakulujen ilmoitetaan olevan NaN, mikä osoittaa NaN%:n muutoksen edellisvuoteen verrattuna. Myynti- ja markkinointikulut ovat NaN, mikä on NaN% muutos edelliseen vuoteen verrattuna. Viimeisimpiin lukuihin perustuva käyttökate on NaN, mikä vastaa NaN%:n kasvua edellisvuoteen verrattuna. Liikevoitto on NaN, joka osoittaa NaN%:n muutosta edelliseen vuoteen verrattuna. Nettotuloksen muutos on NaN%. Viime vuoden nettotulos oli NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

income-statement-row.row.total-revenue

015281144.11106
781.4
761.3
1045.7
1204.6
832.4
801.9
784.1
957.3
957.6
976.7
1019.3
1754.9
1750.4
1015.2
987.8
1008.2
784.5
631.1
401.1
283.8
165.2
148.1
133
125.1
102.3
61.3

income-statement-row.row.cost-of-revenue

0985.4718.3720.8
566.8
603.9
756.2
889.3
610.7
587.1
563.5
736.5
817.9
740.1
743.5
1320
1314.5
815.5
691.9
748.1
554.8
448.5
224.2
141.1
96.9
95.8
75.3
78
67.4
39.6

income-statement-row.row.gross-profit

0542.6425.8385.2
214.6
157.3
289.5
315.3
221.7
214.8
220.6
220.8
139.7
236.6
275.9
434.9
435.9
199.8
295.9
260.1
229.7
182.6
176.9
142.8
68.3
52.3
57.6
47.2
34.9
21.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0101.394.541.9
90.8
-3.2
5.9
12.4
42.4
-2.3
3.6
12.1
9.9
21.1
3.8
6.5
5.3
-3.3
9.5
-4.8
6.6
8.2
2.4
2.3
16.1
8.2
0
4.2
3.8
3.6

income-statement-row.row.operating-expenses

0298.4338.1201.8
320.7
390.5
288
282.8
246.3
189.9
188.2
212.7
232.7
210
207.4
305.1
271.9
240.8
218.9
188.1
121.2
87.9
60.2
44.3
22.8
20
8.8
6.4
3.8
5

income-statement-row.row.cost-and-expenses

01283.71056.4922.6
887.6
994.5
1044.2
1172.1
856.9
777
751.7
949.3
1050.6
950.1
950.9
1625.1
1586.4
1056.3
910.8
188.1
676
536.4
284.3
185.4
119.7
115.8
84.2
84.3
71.1
44.6

income-statement-row.row.interest-income

00.20.30.2
0.2
0.3
2.1
4.3
5.7
0.9
0.4
1.3
1.5
1.4
0
0.6
1.4
6
3.9
18.4
5.4
9.5
1.3
2.7
0
0
0
0
0
0

income-statement-row.row.interest-expense

018.914.520.2
64.2
64.8
14.9
9.2
17.6
57
52.1
73.6
76.2
91.9
105
138.4
108.8
89.7
81.3
53.8
49.5
32.3
22.4
11
3.6
3.3
2.7
1.5
0.9
0.8

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-521.4-992.9-26.5
-1265.4
-468.3
5.9
12
40.8
-2.6
3.5
12
9.9
20.4
-25.4
-57.4
-8.8
-10.2
2.4
2.3
2.2
3.1
1.8
1.8
11.4
8.7
-0.1
0
-0.1
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0101.394.541.9
90.8
-3.2
5.9
12.4
42.4
-2.3
3.6
12.1
9.9
21.1
3.8
6.5
5.3
-3.3
9.5
-4.8
6.6
8.2
2.4
2.3
16.1
8.2
0
4.2
3.8
3.6

income-statement-row.row.total-operating-expenses

0-521.4-992.9-26.5
-1265.4
-468.3
5.9
12
40.8
-2.6
3.5
12
9.9
20.4
-25.4
-57.4
-8.8
-10.2
2.4
2.3
2.2
3.1
1.8
1.8
11.4
8.7
-0.1
0
-0.1
-0.1

income-statement-row.row.interest-expense

018.914.520.2
64.2
64.8
14.9
9.2
17.6
57
52.1
73.6
76.2
91.9
105
138.4
108.8
89.7
81.3
53.8
49.5
32.3
22.4
11
3.6
3.3
2.7
1.5
0.9
0.8

income-statement-row.row.depreciation-and-amortization

046.947.428.2
-210.7
44.3
42.7
42.2
57.5
46.7
46.6
46.5
49.2
47.8
45.6
85.8
100.8
87.5
86.6
62.4
33.3
27.8
18.8
18.6
15.7
5.3
2.7
-7
-7.2
-6.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0218.659.9109.7
-106.2
-702.8
4.1
24.4
97.3
35.8
18
22.5
-201
-104.3
100.6
-110
46.8
-160.8
12.2
109.3
109.3
78.6
98.8
92.7
50.2
31.4
46.1
47.8
38.4
22.9

income-statement-row.row.income-before-tax

0-302.7-93383.2
-1371.5
-701.5
10.1
36.4
138.1
33.2
21.5
34.5
-191.1
-83.9
75.2
-167.4
38
-171
14.6
111.6
111.5
81.7
100.7
94.5
61.6
40.2
46.1
47.8
38.3
22.9

income-statement-row.row.income-tax-expense

033.935.521.1
11.3
39.3
-3.9
19.9
35.5
10.2
9.1
8.7
-3.6
-12.1
29.9
18.2
11.8
9.9
10.4
9.1
17.3
12.9
7.3
5.5
12.3
9.5
6.9
7.2
3
3

income-statement-row.row.net-income

0-336.6-968.558.3
-1382.8
-706
10.2
12.9
102.5
26.1
12.2
24.1
-178.4
-74.1
39.9
-198.4
11.7
-183.4
0.9
7.1
90.1
66.8
92.5
87.6
48.3
29
26.4
28.9
26.3
18.4

Usein kysytty kysymys

Mikä on Galaxy Biomedical Investment Co., Ltd. (000806.SZ) taseen loppusumma?

Galaxy Biomedical Investment Co., Ltd. (000806.SZ) kokonaisvarat ovat 2006523043.000.

Mikä on yrityksen vuotuinen liikevaihto?

Vuotuinen liikevaihto on N/A.

Mikä on yrityksen voittomarginaali?

Yrityksen voittomarginaali on 0.350.

Mikä on yrityksen vapaa kassavirta?

Vapaa kassavirta on -0.372.

Mikä on yrityksen nettovoittomarginaali?

Nettovoittomarginaali on -0.407.

Mikä on yrityksen kokonaistulot?

Kokonaisliikevaihto on -0.294.

Mikä on Galaxy Biomedical Investment Co., Ltd. (000806.SZ) nettovoitto (nettotulos)?

Nettovoitto (nettotulos) on -336600471.300.

Mikä on yrityksen kokonaisvelka?

Kokonaisvelka on 198468358.000.

Mikä on yrityksen toimintakulujen määrä?

Toimintakulut ovat 298367799.000.

Mikä on yrityksen kassan määrä?

Yrityksen kassavarat ovat 0.000.